Embolic stroke

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
ATC code not specified 1
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Antiplatelet / NSAID 1 substance
Factor Xa inhibitor (DOAC) 1 substance
Phase IV: 1 Phase I (Other): 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase IV

1 trial
  • University Of Ottawa Heart Institute Academic
    ACETYLSALICYLIC ACID; RIVAROXABAN
    2024-518736-37-00 2 countries 2018 n=282
    Ended

Phase I (Other)

1 trial
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Bayer AG Commercial 1 Phase I (Other) 0
University Of Ottawa Heart Institute Academic 1 Phase IV 0
New trials by year
2024
1
← All indication landscapes